ACE2 and COVID-19: As a decoy, recombinant soluble ACE2 or ACE2-Fc fusion protein is a therapeutic countermeasure for use against COVID-19, but the specificity and affinity of wild-type ACE2 are usually lower than those of the ACE2-blocking MAb h11B112,29.